130 related articles for article (PubMed ID: 22186134)
1. Synthesis and immobilization of micro-scale drug particles in presence of β-cyclodextrins.
Meng X; Yang D; Keyvan G; Michniak-Kohn B; Mitra S
Colloids Surf B Biointerfaces; 2012 Apr; 92():213-22. PubMed ID: 22186134
[TBL] [Abstract][Full Text] [Related]
2. Hydroxypropyl chitosan bearing beta-cyclodextrin cavities: synthesis and slow release of its inclusion complex with a model hydrophobic drug.
Prabaharan M; Mano JF
Macromol Biosci; 2005 Oct; 5(10):965-73. PubMed ID: 16208630
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of hydroxypropyl methyl cellulose films containing stable BCS Class II drug nanoparticles for pharmaceutical applications.
Sievens-Figueroa L; Bhakay A; Jerez-Rozo JI; Pandya N; Romañach RJ; Michniak-Kohn B; Iqbal Z; Bilgili E; Davé RN
Int J Pharm; 2012 Feb; 423(2):496-508. PubMed ID: 22178619
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and immobilization of micro-scale drug particles in cellulosic films.
Meng X; Yang D; Keyvan G; Michniak-Kohn B; Mitra S
Colloids Surf B Biointerfaces; 2011 Aug; 86(1):181-8. PubMed ID: 21524894
[TBL] [Abstract][Full Text] [Related]
5. Enhanced dissolution of megestrol acetate microcrystals prepared by antisolvent precipitation process using hydrophilic additives.
Cho E; Cho W; Cha KH; Park J; Kim MS; Kim JS; Park HJ; Hwang SJ
Int J Pharm; 2010 Aug; 396(1-2):91-8. PubMed ID: 20558265
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of bioavailability of griseofulvin by its complexation with beta-cyclodextrin.
Dhanaraju MD; Kumaran KS; Baskaran T; Moorthy MS
Drug Dev Ind Pharm; 1998 Jun; 24(6):583-7. PubMed ID: 9876628
[TBL] [Abstract][Full Text] [Related]
7. Loading antifungal drugs onto silica particles grafted with cyclodextrins by means of inclusion complex formation at the solid surface.
Hbaieb S; Kalfat R; Chevalier Y
Int J Pharm; 2012 Dec; 439(1-2):234-45. PubMed ID: 23018113
[TBL] [Abstract][Full Text] [Related]
8. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
9. Comparative interaction of 2-hydroxypropyl-beta-cyclodextrin and sulfobutylether-beta-cyclodextrin with itraconazole: phase-solubility behavior and stabilization of supersaturated drug solutions.
Brewster ME; Vandecruys R; Peeters J; Neeskens P; Verreck G; Loftsson T
Eur J Pharm Sci; 2008 Jul; 34(2-3):94-103. PubMed ID: 18420390
[TBL] [Abstract][Full Text] [Related]
10. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
Jug M; Maestrelli F; Bragagni M; Mura P
J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
[TBL] [Abstract][Full Text] [Related]
11. Influence of soluble and insoluble cyclodextrin polymers on drug release from hydroxypropyl methylcellulose tablets.
Zugasti ME; Zornoza A; Goñi Mdel M; Isasi JR; Vélaz I; Martín C; Sánchez M; Martínez-Ohárriz MC
Drug Dev Ind Pharm; 2009 Oct; 35(10):1264-70. PubMed ID: 19555243
[TBL] [Abstract][Full Text] [Related]
12. Stabilizing dispersions of hydrophobic drug molecules using cellulose ethers during anti-solvent synthesis of micro-particulates.
Meng X; Chen Y; Chowdhury SR; Yang D; Mitra S
Colloids Surf B Biointerfaces; 2009 Apr; 70(1):7-14. PubMed ID: 19155163
[TBL] [Abstract][Full Text] [Related]
13. In situ Raman and UV-vis spectroscopic studies of polypyrrole and poly(pyrrole-2,6-dimethyl-β-cyclodextrin).
Arjomandi J; Shah AU; Bilal S; Van Hoang H; Holze R
Spectrochim Acta A Mol Biomol Spectrosc; 2011 Jan; 78(1):1-6. PubMed ID: 21111671
[TBL] [Abstract][Full Text] [Related]
14. A hydrotropic β-cyclodextrin grafted hyperbranched polyglycerol co-polymer for hydrophobic drug delivery.
Zhang X; Zhang X; Wu Z; Gao X; Cheng C; Wang Z; Li C
Acta Biomater; 2011 Feb; 7(2):585-92. PubMed ID: 20813209
[TBL] [Abstract][Full Text] [Related]
15. Effect of water-soluble polymers on naproxen complexation with natural and chemically modified beta-cyclodextrins.
Faucci MT; Mura P
Drug Dev Ind Pharm; 2001 Oct; 27(9):909-17. PubMed ID: 11763468
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Liu L; Zhu S
J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
[TBL] [Abstract][Full Text] [Related]
17. Effect of 2-hydroxypropyl-beta-cyclodextrin on the solubility, stability, and pharmacological activity of the chemical delivery system of TRH analogs.
Wu WM; Wu J; Bodor N
Pharmazie; 2002 Feb; 57(2):130-4. PubMed ID: 11878189
[TBL] [Abstract][Full Text] [Related]
18. Drug product development and pharmacological evaluation of a sparingly soluble novel camptothecin analog for peroral administration.
Nekkanti V; Karatgi P; Paruchuri S; Pillai R
Drug Deliv; 2011 May; 18(4):294-303. PubMed ID: 21214430
[TBL] [Abstract][Full Text] [Related]
19. Preparation of amorphous indomethacin from aqueous 2,6-di-O-methyl-beta-cyclodextrin solution.
Iohara D; Hirayama F; Ishiguro T; Arima H; Uekama K
Int J Pharm; 2008 Apr; 354(1-2):70-6. PubMed ID: 18093762
[TBL] [Abstract][Full Text] [Related]
20. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery.
Sajeesh S; Sharma CP
Int J Pharm; 2006 Nov; 325(1-2):147-54. PubMed ID: 16859846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
